Monday January 21, 2019
Home Lead Story Johnson &...

Johnson & Johnson’s Stock Falls After Reports Of Presence of Asbestos

The controversy has long dogged the company, which has been battling more than 10,000 cases claiming its Baby Powder and Shower to Shower products cause ovarian cancer.

0
//
Johnson & Johnson, asbestos
Bottles of Johnson & Johnson baby powder line a drugstore shelf in New York, Oct. 15, 2015. VOA

Johnson & Johnson saw its stocks suffer their biggest drop in 16 years, following a media report that alleged the company concealed for decades that trace amounts of asbestos was in its baby powder.

Shares of the U.S. pharmaceutical and cosmetics group fell 9 percent Friday, wiping out tens of billions of dollars from the company’s market capitalization.

Linked to ovarian cancer

The report Friday, by Reuters news service, cited documents released as part of a lawsuit by plaintiffs claiming that Johnson & Johnson’s baby powder can be linked to ovarian cancer.

Ovarian Cancer, asbestos
The study found that genes on the X-chromosome get potentially passed down through the father to his daughter, thus increasing the risk of ovarian cancer in girls. Wikimedia Commons

It said that the company’s executives knew the baby powder contained trace amounts of asbestos, from as early as 1971, but deliberately chose not to make the information public.

The Reuters report also alleged that Johnson & Johnson tried, unsuccessfully, to stop regulators from lowering the maximum level of asbestos allowed in talc-based cosmetics.

Report is strongly denied

Johnson & Johnson strongly denied the report Friday, calling it “one-sided, false and inflammatory.”

asbestos
Toribio Jimenez lies on his bed in his basement bedroom of the home where he and 10 other people live in Nashville, Tenn, Sept. 3, 2009. Jimenez was given a job removing asbestos in the U.S. through the H2-B nonagricultural guest worker program. The job was not the job that was promised to him through the program, and after being fired, Jimenez said he now has no option but to work illegally so he can pay back the money he borrowed to make the trip to the U.S. VOA

“Simply put, the Reuters story is an absurd conspiracy theory,” the company said in a statement. “Johnson & Johnson’s baby powder is safe and asbestos-free.”

The controversy has long dogged the company, which has been battling more than 10,000 cases claiming its Baby Powder and Shower to Shower products cause ovarian cancer.

Also Read: Prenatal Interaction With Baby Important For Development

Investors worry the lawsuits will cost the company billions of dollars in damages and loss of future sales of Johnson & Johnson products. (VOA)

Next Story

Regular Dose of Aspirin Reduces Risk of Ovarian Cancer

For this study, published in the journal JAMA Oncology, the team analysed data on more than 200,000 women among which 1,054 developed ovarian cancer

0
Aspirin, Ovarian cancer
Aspirin pills are arranged on a counter in New York, Aug. 23, 2018. New studies find most people won't benefit from taking daily low-dose aspirin to prevent a first heart attack or stroke. (VOA)

Taking a low-dose of aspirin daily may help women lower their risk of developing ovarian cancer by 23 per cent, suggests a new study.

Ovarian cancer is the most fatal gynaecological cancer, largely due to lack of early detection strategies and is believed that the inflammation that occurs during ovulation plays a role in the development of this cancer.

Aspirin is thought to lower cancer risk by reducing inflammation.

The findings, led by researchers from H. Lee Moffitt Cancer Centre and Research Institute in the US, showed that low-dose aspirin use was associated with a lower risk of ovarian cancer while standard-dose aspirin use increased the risk, their findings revealed.

Aspirin
Aspirin may lower risk of ovarian cancer. Pixabay

Conversely, women who took non-aspirin anti-inflammatory drugs (NSAIDs), such as ibuprofen (Advil) or naproxen (Aleve) — at least 10 tablets per week for many years, had an increased risk of developing the disease.

“We’re not quite at the stage where we could make the recommendation that daily aspirin use lowers ovarian cancer risk. We need to do more research. But it is definitely something women should discuss with their physician,” said Shelley Tworoger, Associate Centre Director from the varsity.

Also Read- Google Assistant Revamps its Interface on Android Devices

For this study, published in the journal JAMA Oncology, the team analysed data on more than 200,000 women among which 1,054 developed ovarian cancer.

In addition, researchers looked at the participants’ use of aspirin (325 milligrams), low-dose aspirin (100 milligrams or less), non-aspirin NSAIDs and acetaminophen. (IANS)